European consensus table 2006 on botulinum toxin for children with cerebral palsy
- PMID: 17097905
- DOI: 10.1016/j.ejpn.2006.08.006
European consensus table 2006 on botulinum toxin for children with cerebral palsy
Abstract
An interdisciplinary group of experienced botulinum toxin users and experts in the field of movement disorders was assembled, to develop a consensus on best practice for the treatment of cerebral palsy using a problem-orientated approach to integrate theories and methods. The authors tabulated the supporting evidence to produce a condensed but comprehensive information base, pooling data and experience from nine European countries, 13 institutions and more than 5500 patients. The consensus table summarises the current understanding regarding botulinum toxin treatment options in children with CP.
Similar articles
-
The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy.Eur J Paediatr Neurol. 2010 Jan;14(1):45-66. doi: 10.1016/j.ejpn.2009.09.005. Epub 2009 Nov 14. Eur J Paediatr Neurol. 2010. PMID: 19914110 Review.
-
[Botulinum toxin in the treatment of cerebral palsy].Harefuah. 2000 Jan 16;138(2):144-7. Harefuah. 2000. PMID: 10883079 Review. Hebrew. No abstract available.
-
When it comes to botulinum toxin, children and adults are not the same: multimuscle option for children with cerebral palsy.Mov Disord. 2006 Nov;21(11):2029-30. doi: 10.1002/mds.21097. Mov Disord. 2006. PMID: 16972275 Clinical Trial. No abstract available.
-
Children undergoing treatment with botulinum toxin: the role of the physical therapist.Muscle Nerve Suppl. 1997;6:S194-207. Muscle Nerve Suppl. 1997. PMID: 9826991 Review.
-
Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment.Muscle Nerve Suppl. 1997;6:S181-93. Muscle Nerve Suppl. 1997. PMID: 9826990 Review.
Cited by
-
Muscle type-specific effects of bilateral abobotulinumtoxinA injection on muscle growth and contractile function in spastic mice.FASEB J. 2024 Nov 30;38(22):e70141. doi: 10.1096/fj.202302258R. FASEB J. 2024. PMID: 39560920 Free PMC article.
-
Onabotulinumtoxina in the Prevention of Migraine in Pediatric Population: A Systematic Review.Toxins (Basel). 2024 Jun 28;16(7):295. doi: 10.3390/toxins16070295. Toxins (Basel). 2024. PMID: 39057935 Free PMC article.
-
Botulinum Toxin Intervention in Cerebral Palsy-Induced Spasticity Management: Projected and Contradictory Effects on Skeletal Muscles.Toxins (Basel). 2022 Nov 8;14(11):772. doi: 10.3390/toxins14110772. Toxins (Basel). 2022. PMID: 36356022 Free PMC article. Review.
-
Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy-A Secondary Analysis of the Randomized Clinical Trial.Toxins (Basel). 2017 Aug 21;9(8):253. doi: 10.3390/toxins9080253. Toxins (Basel). 2017. PMID: 28825663 Free PMC article. Clinical Trial.
-
Relation of selective voluntary motor control of the lower extremity and extensor strength of the knee joint in children with spastic diplegia.J Phys Ther Sci. 2016 Jun;28(6):1868-71. doi: 10.1589/jpts.28.1868. Epub 2016 Jun 28. J Phys Ther Sci. 2016. PMID: 27390436 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous